Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1979 1
1980 2
1982 1
1983 4
1984 3
1985 3
1986 2
1987 7
1988 2
1989 5
1990 9
1991 10
1992 6
1993 8
1994 12
1995 11
1996 12
1997 7
1998 8
1999 12
2000 12
2001 19
2002 11
2003 16
2004 14
2005 17
2006 8
2007 8
2008 10
2009 8
2010 10
2011 6
2012 11
2013 11
2014 15
2015 12
2016 26
2017 17
2018 33
2019 36
2020 35
2021 32
2022 42
2023 33
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Results by year

Filters applied: . Clear all
Page 1
Ferroptosis model system by the re-expression of BACH1.
Irikura R, Nishizawa H, Nakajima K, Yamanaka M, Chen G, Tanaka K, Onodera M, Matsumoto M, Igarashi K. Irikura R, et al. Among authors: igarashi k. J Biochem. 2023 Jul 31;174(3):239-252. doi: 10.1093/jb/mvad036. J Biochem. 2023. PMID: 37094356
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
Blauvelt A, Leonardi CL, Gooderham M, Papp KA, Philipp S, Wu JJ, Igarashi A, Flack M, Geng Z, Wu T, Camez A, Williams D, Langley RG. Blauvelt A, et al. Among authors: igarashi a. JAMA Dermatol. 2020 Jun 1;156(6):649-658. doi: 10.1001/jamadermatol.2020.0723. JAMA Dermatol. 2020. PMID: 32267471 Free PMC article. Clinical Trial.
Therapeutic potential for KCC2-targeted neurological diseases.
Tomita K, Kuwahara Y, Igarashi K, Kitanaka J, Kitanaka N, Takashi Y, Tanaka KI, Roudkenar MH, Roushandeh AM, Kurimasa A, Nishitani Y, Sato T. Tomita K, et al. Among authors: igarashi k. Jpn Dent Sci Rev. 2023 Dec;59:431-438. doi: 10.1016/j.jdsr.2023.11.001. Epub 2023 Nov 11. Jpn Dent Sci Rev. 2023. PMID: 38022385 Free PMC article. Review.
Patients with neurological diseases, such as schizophrenia, tend to show low K(+)-Cl(-) co-transporter 2 (KCC2) levels in the brain. The cause of these diseases has been associated with stress and neuroinflammation. ...
Patients with neurological diseases, such as schizophrenia, tend to show low K(+)-Cl(-) co-transporter 2 (KCC2) levels in the brain. …
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Saeki S, Iwatani T, Kitano A, Sakurai N, Tanabe Y, Yamauchi C, Igarashi A, Kajimoto Y, Kuba S, Hara F, Sagara Y, Ohno S; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Saeki S, et al. Among authors: igarashi a. Breast Cancer. 2023 Sep;30(5):820-830. doi: 10.1007/s12282-023-01476-z. Epub 2023 Jun 13. Breast Cancer. 2023. PMID: 37310584 Free PMC article.
Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editing.
Yoshimatsu S, Okahara J, Yoshie J, Igarashi Y, Nakajima R, Sanosaka T, Qian E, Sato T, Kobayashi H, Morimoto S, Kishi N, Pillis DM, Malik P, Noce T, Okano H. Yoshimatsu S, et al. Among authors: igarashi y. Cell Rep Methods. 2023 Sep 25;3(9):100590. doi: 10.1016/j.crmeth.2023.100590. Epub 2023 Sep 14. Cell Rep Methods. 2023. PMID: 37714158 Free PMC article.
530 results